ETCM
KRYS icon

Evolutionary Tree Capital Management’s Krystal Biotech KRYS Stock Holding History

Evolutionary Tree Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.18M Sell
12,314
-4,497
-27% -$1.2M 5.98% 3
2025
Q4 		$4.14M Buy
16,811
+4,350
+35% +$916K 4.81% 5
2025
Q3 		$2.2M Buy
12,461
+165
+1% +$24.7K 2.4% 21
2025
Q2 		$1.69M Sell
12,296
-1,047
-8% -$154K 1.79% 24
2025
Q1 		$2.41M Buy
13,343
+2,643
+25% +$445K 2.8% 16
2024
Q4 		$1.68M Buy
10,700
+1,588
+17% +$282K 1.71% 25
2024
Q3 		$1.66M Buy
9,112
+177
+2% +$34.1K 1.66% 24
2024
Q2 		$1.64M Sell
8,935
-161
-2% -$27K 1.69% 25
2024
Q1 		$1.62M Sell
9,096
-1,476
-14% -$205K 1.63% 27
2023
Q4 		$1.31M Buy
+10,572
New +$1.17M 1.45% 29

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return